Inventaire - your friends and communities are your best library

Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination

author

Reinaldo M. Martins

Denise Silveira Lemos

Olindo Assis Martins-Filho

Akira Homma

Vanessa Peruhype-Magalhães

Andréa Teixeira de Carvalho

Silvana Maria Elói-Santos

published in: Clinical and Vaccine Immunology

date of publication: 2009-11-11

main subject: yellow fever virus, yellow fever

Cites articles 23

Date

Title

Authors

2008-09-20

Adverse event reports following yellow fever vaccination

J. Erin Staples, Nina Marano, Nicole P Lindsey, Gary W Brunette
2008-08-01

Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes

Bali Pulendran, Rafi Ahmed, Claudia Vellozzi
2008-05-01

Yellow fever-associated viscerotropic disease in Barcelona, Spain

Joaquim Gascón, Fernando de Ory, Antonio Tenorio
2008-06-01

Immune response during adverse events after 17D-derived yellow fever vaccination in Europe

Matthias Niedrig, Fernando de Ory, Antonio Tenorio
2008-01-14

Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination

Erna G. Kroon, Vanessa Peruhype-Magalhães, Andréa Teixeira de Carvalho, Silvana Maria Elói-Santos
2007-09-18

Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease

Robert S. Lanciotti, Sherif Zaki, Christopher D. Paddock, Bali Pulendran
2007-04-01

Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?

Rodrigo Corrêa-Oliveira, Erna G. Kroon
2006-11-27

Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases.

James J Sejvar, Robert T. Chen, Anthony A Marfin, Martin S Cetron
2006-04-04

Yellow fever vaccine-associated viscerotropic disease and death in Spain

Cristina Domingo Carrasco
2006-01-18

Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil

Pedro F C Vasconcelos, Alan D T Barrett
2006-10-01

Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection

Teresa Cristina de Abreu Ferrari, Johan Van Weyenbergh
2005-06-30

Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial
2005-05-01

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

Leisa Weld, Katrin Susanne Kohl, Robert T. Chen
2005-09-01

Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes

Rodrigo Corrêa-Oliveira
2004-01-01

Age-related risk of adverse events following yellow fever vaccination in Australia
2004-02-01

Yellow Fever Immunizations: Indications and Risks

Lin Hwei Chen
2004-09-01

History of thymoma and yellow fever vaccination
2001-08-01

Yellow fever: an update

Thomas P. Monath
2001-07-01

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases

Leisa Weld
2001-07-01

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

Thomas P. Monath
2001-07-01

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

William D. Rawlinson
1996-06-01

Expanded programme on immunization (EPI). Inclusion of yellow fever vaccine in the EPI
1994-03-01

Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis

Article - wd:Q33613475

Welcome to Inventaire

the library of your friends and communities

learn more